An Efficient Iodine-Catalyzed
Benzylation Reaction of 1,3-Dicarbonyl Compounds

Zhongxian Li; Zheng Duan; Huaiqiu Wang; Rongqiang Tian; Qianrui Zhu; Yangjie Wu

doi:10.1055/s-2008-1078216

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Synlett 2008(16): 2535-2539
DOI: 10.1055/s-2008-1078216

LETTER

An Efficient Iodine-Catalyzed Benzylation Reaction of 1,3-Dicarbonyl Compounds

Zhongxian Li, Zheng Duan*, Huaiqiu Wang, Rongqiang Tian, Qianrui Zhu, Yangjie Wu*
Chemistry Department, The Key Lab of Chemical Biology and Organic Chemistry of Henan Province, The Key and Open Lab of Applied Chemistry of Henan Universities, Zhengzhou University, Zhengzhou 450052, P. R. of China
Fax: +86(371)67979408; e-Mail: duanzheng@zzu.edu.cn; e-Mail: wyj@zzu.edu.cn;

Further Information

Publication History

Received 13 May 2008
Publication Date:
22 August 2008 (online)

Abstract
Full Text
References
Supplementary Material

Permissions and Reprints All articles of this category

Abstract

Under mild conditions, iodine promotes the direct alkylation of 1,3-dicarbonyl compounds with benzylic alcohols or benzylic acetates.

Key words

iodine - catalysis - benzylation - Friedel-Crafts - C-H activation

Supporting Information

References and Notes

1 Ritleng V. Sirlin C. Pfeffer M. Chem. Rev. 2002, 102: 1731

Google Scholar
2 Kischel J. Mertins K. Michalik D. Zapf A. Beller M. Adv. Synth. Catal. 2007, 349: 865 ; and references cited therein

Crossref Google Scholar
3 Comprehensive Organic Synthesis Vol. 3: Trost BM. Fleming I. Pergamon Press; Oxford: 1991.

Google Scholar
4a Trost BM. Acc. Chem. Res. 2002, 35: 695

Google Scholar
4b Yao X. Li C.-J. J. Am. Chem. Soc. 2004, 126: 6884

Google Scholar
5a Nishibayashi Y. Wakiji I. Ishii Y. Uemura S. Hidai M. J. Am. Chem. Soc. 2001, 123: 3393

Google Scholar
5b Nishibayashi Y. Yoshikawa M. Inada Y. Hidai M. Uemura S. J. Org. Chem. 2004, 69: 3408

Google Scholar
6 Manabe K. Kobayashi S. Org. Lett. 2003, 5: 3241

Crossref PubMed Google Scholar
7 Yasuda M. Somyo T. Baba A. Angew. Chem. Int. Ed. 2006, 45: 793

Crossref Google Scholar
For Bi-catalyzed, see:
8a Rueping M. Nachtsheim BJ. Ieawsuwan W. Adv. Synth. Catal. 2006, 348: 1033

Google Scholar
8b Rueping M. Nachtsheim BJ. Kuenkel A. Org. Lett. 2007, 9: 825

Google Scholar
9 Noji M. Konno Y. Ishii K. J. Org. Chem. 2007, 72: 5161

Crossref Google Scholar
10a Sanz R. Miguel D. Martinez A. Alvarez-Gutierrez JM. Rodriguez F. Org. Lett. 2007, 9: 2027

Google Scholar
10b Sanz R. Miguel D. Martinez A. Alvarez-Gutierrez JM. Rodriguez F. Org. Lett. 2007, 9: 727

Google Scholar
11a Deka N. Kalita DJ. Borah R. Sarma JC. J. Org. Chem. 1997, 62: 1563

Google Scholar
11b Firouzabadi H. Iranpoor N. Hazarkhani H. J. Org. Chem. 2001, 66: 7527

Google Scholar
11c Chu C.-M. Huang W.-J. Liu J.-T. Yao C.-F. Tetrahedron Lett. 2007, 48: 6881 ; and references cited therein

Google Scholar
14 During the preparation of this manuscript, a similar result was reported, see: Srihari P. Bhunia DC. Sreedhar P. Yadav JS. Synlett 2008, 1045

Article in Thieme Connect Google Scholar

12

General Procedure
All procedures were carried out under air. To a 10 mL flask, benzylic alcohols or benzylic acetates (0.5 mmol), 1,3-dicarbonyl compounds, MeNO₂ (2 mL), and molecular iodine (13 mg, 0.05 mmol) were added successively. The mixture was magnetically stirred at 80 ˚C. After completion of the reaction (by GC), the solvent was concentrated under reduced pressure by an aspirator, and the residue was purified by preparative TLC using PE-EtOAc (10:1) as an eluent to afford products.

13

Selected Spectroscopic Data All prepared compounds were known and identified by ^¹H NMR, ^¹³C NMR, and MS.
Compound 3a: ^¹H NMR (400 MHz, CDCl₃): δ = 7.31-7.27 (m, 2 H), 7.22-7.18 (m, 3 H), 4.04 (d, J = 11.3 Hz, 1 H), 3.63-3.55 (m, 1 H), 2.56 (s, 3 H), 1.83 (s, 3 H), 1.21 (d, J = 6.9 Hz, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 203.5, 203.4, 143.0, 128.8, 127.3, 127.0, 76.7, 40.4, 29.8, 29.7, 20.8. ESI-MS: m/z = 227.0 [M + Na⁺].
Compound 3b: ^¹H NMR (400 MHz, CDCl₃): δ = 7.28-7.25 (m, 2 H), 7.15-7.12 (m, 2 H), 4.00 (d, J = 11.3 Hz, 1 H), 3.61-3.57 (m, 1 H), 2.26 (s, 3 H), 1.87 (s, 3 H), 1.19 (d, J = 6.9 Hz, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 203.0, 202.9, 141.5, 132.6, 128.9, 128.6, 76.5, 39.6, 29.8, 29.6, 20.7. ESI-MS: m/z = 261.1 [M + Na⁺].
Compound 3c: ^¹H NMR (400 MHz, CDCl₃): δ = 7.12-7.08 (m, 2 H), 6.84-6.82 (m, 2 H), 3.98 (d, J = 11.3 Hz, 1 H), 3.78 (s, 3 H), 3.57-3.53 (m, 1 H), 2.26 (s, 3 H), 1.84 (s, 3 H), 1.18 (d, J = 6.9 Hz, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 203.6, 203.5, 158.4, 134.9, 128.2, 114.1, 76.9, 55.1, 39.7, 29.8, 29.6, 20.9. ESI-MS: m/z = 257.0 [M + Na⁺].
Compound 3d: ^¹H NMR (400 MHz, CDCl₃): δ = 7.22-7.18 (m, 2 H), 7.14-7.12 (m, 1 H), 6.97 (d, J = 7.8 Hz, 2 H), 6.88 (s, 1 H), 6.69 (s, 1 H), 5.48 (d, J = 11.7 Hz, 1 H), 4.94 (d, J = 11.7 Hz, 1 H), 2.55 (s, 3 H), 2.29 (s, 3 H), 2.20 (s, 3 H), 1.99 (s, 3 H), 1.83 (s, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 203.7, 203.0, 141.1, 137.3, 136.7, 136.7, 134.9, 131.3, 129.6, 128.4, 126.9, 126.1, 70.5, 43.0, 30.3, 28.9, 21.7, 20.9, 20.7. Anal. Calcd for: C, 81.78; H, 7.84. Found: C, 81.74; H, 7.93.
Compound 3e: ^¹H NMR (400 MHz, CDCl₃): δ = 7.22-7.18 (m, 2 H), 7.14-7.11 (m, 1 H), 6.94 (d, J = 7.9 Hz, 2 H), 6.88 (s, 1 H), 5.67 (d, J = 11.3 Hz, 1 H), 4.94 (d, J = 11.3 Hz, 1 H), 2.46 (s, 3 H), 2.34 (s, 3 H), 2.28 (s, 3 H), 2.08 (s, 3 H), 1.88 (s, 3 H), 1.72 (s, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 203.8, 202.8, 142.0, 137.9, 135.3, 134.1, 133.8, 133.1, 131.3, 128.5, 126.8, 126.0, 71.9, 43.3, 29.8, 29.2, 21.5, 20.4, 17.1, 16.8. Anal. Calcd for: C, 81.95; H, 8.13. Found: C, 81.64; H, 8.37.
Compound 3f: ^¹H NMR (400 MHz, CDCl₃): δ = 7.32 (d, J = 8.4 Hz, 2 H), 6.88 (s, 1 H), 6.84 (d, J = 8.3 Hz, 2 H), 6.71 (s, 1 H), 5.40 (d, J = 11.6 Hz, 1 H), 4.89 (d, J = 11.6 Hz, 1 H), 2.53 (s, 3 H), 2.29 (s, 3 H), 2.21 (s, 3 H), 1.98 (s, 3 H), 1.83 (s, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 203.3, 202.6, 140.4, 137.3, 137.0, 136.6, 134.4, 131.5 (2C), 129.8, 128.8, 120.0, 70.4, 42.5, 30.3, 29.0, 21.7, 21.0, 20.7. Anal. Calcd for: C, 65.12; H, 5.99. Found: C, 65.03; H, 6.04.
Compound 3g: ^¹H NMR (400 MHz, CDCl₃): δ = 7.01 (d, J = 8.0 Hz, 2 H), 6.87-6.85 (m, 3 H), 6.69 (s, 1 H), 5.42 (d, J = 11.7 Hz, 1 H), 4.92 (d, J = 11.7 Hz, 1 H), 2.55 (s, 3 H), 2.29 (s, 3 H), 2.26 (s, 3 H), 2.21 (s, 3 H), 2.01 (s, 3 H), 1.82 (s, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 204.0, 203.2, 138.1, 137.3, 136.8, 136.7, 135.7, 135.1, 131.4, 129.7, 129.1, 126.9, 70.8, 42.9, 30.2, 28.9, 21.8, 21.0, 20.9, 20.8. ESI-MS: m/z = 345.2 [M + Na⁺].
Compound 3h: ^¹H NMR (400 MHz, CDCl₃): δ = 4.19 (s, 5 H), 4.16-4.05 (m, 4 H), 3.59 (d, J = 9.7 Hz, 1 H), 3.29-3.25 (m, 1 H), 2.15 (s, 3 H), 1.87 (s, 3 H), 1.26 (d, J = 6.5 Hz, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 204.5, 203.4, 91.7, 77.3, 68.8, 68.7, 67.8, 67.6, 65.4, 34.6, 32.0, 29.4, 18.3. Anal. Calcd for: C, 65.40; H, 6.46. Found: C, 65.40; H, 6.54.
Compound 3i: ^¹H NMR (400 MHz, CDCl₃): δ = 7.50 (s, 1 H), 7.40 (s, 5 H), 2.43 (s, 3 H), 2.29 (s, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 205.7, 196.6, 142.7, 139.9, 132.8, 130.7, 129.7, 129.0, 31.7, 26.5. ESI-MS: m/z = 211.0 [M + Na⁺].
Compound 3k: ^¹H NMR (400 MHz, CDCl₃): δ = 8.10-8.08 (m, 1 H), 7.49-7.04 (m, 9 H), 4.94 (d, J = 10.9 Hz, 1 H), 3.90-3.86 (m, 1 H), 1.90 (s, 3 H), 1.21 (d, J = 6.8 Hz, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 203.1, 195.2, 143.2, 137.2, 133.9, 128.9, 128.8, 128.5, 127.5, 127.0, 70.8, 41.0, 28.0, 21.6.
Another diastereomer: ^¹H NMR (400 MHz, CDCl₃): δ = 7.80-7.78 (m, 1 H), 7.49-7.04 (m, 9 H), 4.50 (d, J = 11.0 Hz, 1 H), 3.90-3.86 (m, 1 H), 2.23 (s, 3 H), 1.30 (d, J = 7.0 Hz, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 203.6, 195.2, 143.5, 137.0, 133.4, 128.9, 128.6, 128.5, 127.4, 126.6, 71.4, 40.4, 27.6, 20.3.
Compound 3l: ^¹H NMR (400 MHz, CDCl₃): δ = 8.05-8.02 (m, 2 H), 7.74 (d, J = 7.4 Hz, 2 H), 7.57-7.53 (m, 1 H), 7.46-7.39 (m, 3 H), 7.29-7.25 (m, 4 H), 7.19-7.15 (m, 2 H), 7.09-7.05 (m, 1 H), 5.61 (d, J = 10.1 Hz, 1 H), 4.10-4.06 (m, 1 H), 1.34 (d, J = 7.0 Hz, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 195.0, 194.6, 143.8, 137.2, 136.9, 133.6, 133.0, 128.9, 128.8, 128.5, 128.5, 128.4, 127.7, 126.6, 64.9, 41.2, 20.2. ESI-MS: m/z = 351.3 [M + Na⁺].
Compound 3m: ^¹H NMR (400 MHz, CDCl₃): δ = 7.27-7.20 (m, 3 H), 7.14-7.12 (m, 2 H), 3.79 (q, J = 7.0 Hz, 1 H), 2.53-2.46 (m, 2 H), 2.19-2.10 (m, 1 H), 1.97-1.92 (m, 1 H), 1.86 (s, 3 H), 1.84-1.79 (m, 2 H), 1.67-1.55 (m, 2 H), 1.30 (d, J = 7.1 Hz, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 208.6, 205.9, 141.4, 128.7, 128.3, 127.0, 72.1, 42.7, 42.4, 28.2, 26.7, 25.9, 22.2, 17.4. ESI-MS: m/z = 267.1 [M + Na⁺].
Another diastereomer: ^¹H NMR (400 MHz, CDCl₃): δ = 7.28-7.24 (m, 4 H), 7.21-7.19 (m, 1 H), 3.89 (q, J = 7.4 Hz, 1 H), 2.38-2.34 (m, 2 H), 2.16-2.07 (m, 1 H), 2.12 (s, 3 H), 1.67-1.65 (m, 1 H), 1.63-1.60 (m, 1 H), 1.47-1.43 (m, 1 H), 1.42-1.40 (m, 2 H), 1.16 (d, J = 7.4 Hz, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 209.2, 205.4, 141.9, 129.9, 127.8, 126.7, 72.1, 42.3, 41.5, 29.4, 27.1, 25.5, 21.9, 16.2. ESI-MS: m/z = 267.1 [M + Na⁺].
Compound 3n: ^¹H NMR (400 MHz, CDCl₃): δ = 7.30-7.26 (m, 2 H), 7.23-7.7.19 (m, 3 H), 3.87 (q, J = 7.1 Hz, 2 H), 3.81-3.73 (m, 1 H), 3.57-3.52 (m, 1 H), 1.93 (s, 3 H), 1.23 (d, J = 6.9 Hz, 3 H), 0.94 (t, J = 7.2 Hz, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 202.4, 168.6, 143.1, 128.7, 127.4, 126.9, 67.0, 61.5, 40.1, 29.9, 20.6, 14.1. ESI-MS: m/z = 257.1 [M + Na⁺].
Another diastereomer: ^¹H NMR (400 MHz, CDCl₃): δ = 7.30-7.26 (m, 2 H), 7.23-7.7.19 (m, 3 H), 4.23 (q, J = 7.1 Hz, 2 H), 3.81-3.73 (m, 1 H), 3.57-3.52 (m, 1 H), 2.30 (s, 3 H), 1.30 (d, J = 6.9 Hz, 3 H), 1.29 (t, J = 7.2 Hz, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 202.4, 168.2, 143.3, 128.4, 127.5, 126.8, 67.6, 61.1, 39.8, 29.5, 20.4, 13.7. ESI-MS: m/z = 257.1 [M + Na⁺].
Compound 3o: ^¹H NMR (400 MHz, CDCl₃): δ = 7.35-7.32 (m, 2 H), 7.28-7.25 (m, 3 H), 5.27 (s, 1 H), 5.22-5.18 (q, J = 6.4 Hz, 1 H), 2.47-2.43 (m, 2 H), 2.30-2.26 (m, 2 H), 1.98-1.90 (m, 2 H), 1.57 (d, J = 6.4 Hz, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 199.7, 176.5, 141.3, 128.8, 128.0, 125.3, 104.6, 76.6, 36.6, 29.3, 23.6, 21.1.
Compound 5a: ^¹H NMR (400 MHz, CDCl₃): δ = 7.26-7.21 (m, 2 H), 7.17-7.12 (m, 3 H), 6.81 (s, 2 H), 4.63 (q, J = 7.3 Hz, 1 H), 2.25 (s, 3 H), 2.10 (s, 6 H), 1.64 (d, J = 7.3 Hz, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 145.5, 140.1, 136.6, 135.4, 130.0, 128.2, 126.9, 125.3, 37.9, 21.1, 20.8, 16.9.
Compound 5b: ^¹H NMR (400 MHz, CDCl₃): δ = 7.28-7.21 (m, 4 H), 7.17-7.14 (m, 1 H), 5.83 (s, 1 H), 3.89 (q, J = 7.2 Hz, 1 H), 2.20 (s, 3 H), 2.14 (s, 3 H), 1.50 (d, J = 7.3 Hz, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 149.2, 146.6, 144.7, 128.4, 127.1, 125.9, 124.1, 106.0, 35.6, 22.1, 13.6, 11.7.
Compound 5c: ^¹H NMR (400 MHz, CDCl₃): δ = 7.27-7.23 (m, 2 H), 7.19-7.12 (m, 3 H), 6.50 (s, 1 H), 4.08 (q, J = 7.2 Hz, 1 H), 2.35 (s, 3 H), 2.25 (s, 3 H), 1.54 (d, J = 7.2 Hz, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 146.3, 141.5, 135.1, 130.2, 128.4, 127.3, 125.9, 125.3, 38.3, 22.1, 15.4, 13.0. ESI-MS: m/z = 239.4 [M + Na⁺].

Supplementary Material

Supporting Information